The Role of Radiotherapy in Management of Rectal Cancer

직장암 치료에 있어 방사선 치료의 역할

  • Loh Juhn Kyu (Department of Radiation Oncology, Yonsei University, College of Medicine) ;
  • Lee Chang Geol (Department of Radiation Oncology, Yonsei University, College of Medicine) ;
  • Seong Jin Sil (Department of Radiation Oncology, Yonsei University, College of Medicine) ;
  • Kim Soo Kon (Department of Radiation Oncology, Yonsei University, College of Medicine) ;
  • Park Kyung Ran (Department of Radiation Oncology, Yonsei University, College of Medicine) ;
  • Suh Chang Ok (Department of Radiation Oncology, Yonsei University, College of Medicine) ;
  • Kim Gwi Eon (Department of Radiation Oncology, Yonsei University, College of Medicine)
  • 노준규 (연세대학교 의과대학 치료방사선과학교실) ;
  • 이창걸 (연세대학교 의과대학 치료방사선과학교실) ;
  • 성진실 (연세대학교 의과대학 치료방사선과학교실) ;
  • 김수곤 (연세대학교 의과대학 치료방사선과학교실) ;
  • 박경란 (연세대학교 의과대학 치료방사선과학교실) ;
  • 서창옥 (연세대학교 의과대학 치료방사선과학교실) ;
  • 김귀언 (연세대학교 의과대학 치료방사선과학교실)
  • Published : 1988.12.01

Abstract

A total of 93 patients with rectal cancer treated with radiotherapy at department of Radiation Oncology, Yonsei University College of Medicine, Yonsei Cancer Center between January 1974 and December 1983 are retrospectively analysed. The patients are divided into three groups as follows: I. Postoperative radiotherapy, II. Postoperative recurrent, III. Unresectable or Inoperable group. In postoperative radiotherapy group, overall 5 year survival rate is $34.8\%$ and prognostic factors are presence of obstruction and degree of differentiation. In postoperative recurrent group, overall 2 year survival rate is $7.4\%$ with median survival of 13 months and prognostic factors are RT responsiveness and sex, and the local failure rate is $22.7\%$. In unresectable or inoperable group, overall 2 year survival rate is $19.8\%$ with median survival of 12.6 months and prognostic factors are RT responsiveness and RT dose. The complications for RT are not significant and are acceptable in all patients.

Keywords